CiBOR develops advanced composite materials for bioscience and medical applications, including orthopedic implants. Mr. Sullivan earned his degree in economics from Benedictine College in Atchinson and has led four start-ups in life sciences during his career. Most recently, Mr. Sullivan served as CEO of Interface Biologics in Toronto, Ontario.
Read the Wichita Examiner report on Richard Sullivan.
Read more about biomaterials companies:
– Akron Biomaterials Commercialization Hub Receives $250,000 Grant for New Technology Development
– B1 Medical, Invibio Create Development Partnership for New PEEK-OPTIMA System
– Wound Management Technologies Acquires Resorbable Orthopedics
